Studies have shown a 14-34% reduction in the development of diabetes with the use of ACE Inhibitors and ARB’s (angiotensin II receptor antagonists).
Read More »Avandia® Aids Recovery of Insulin-Secreting Cells
The anti-diabetes drug Avandia not only improves the body’s response to insulin but also helps insulin-producing cells in the pancreas recover their function.
Read More »CRP Levels Predict Type 1 Diabetes
Patients with diabetes suffered significantly greater dyslipidemia and activated hemostasis and inflammation than those without diabetes.
Read More »Vitamin E Good or Bad for Those with Diabetes?
Last week a study came out that said it was bad, this week we have a study that says it’s good?
Read More »Calendar Influences Timing of Pediatric Diabetes Diagnosis
Diagnosis of Type 1 diabetes is more common in the winter.
Read More »Experts Warn of Diabetes ‘Time Bomb’
The NHS must pay more attention to the long term complications caused by type 2 diabetes, experts warned last week.
Read More »Plasma Iron Linked With Mortality in Diabetes After MI
Plasma iron appears to be a powerful predictor of mortality.
Read More »DHEA Improves Insulin Action and Fights Abdominal Fat
The hormone dehydroepiandrosterone, or DHEA, significantly reduces abdominal fat and improves insulin action in the elderly, a U.S. study has determined.
Read More »Using Statins and Fibrates Increase Risk of Peripheral Neuropathy
Those on Statins and Fibrates showed an increased risk of peripheral neuropathy greater then those on only statins.
Read More »Cardiovascular Events Declining In US Diabetics, BUT!
Between 1950 and 1995, there was a 50% drop in the rate of incident cardiovascular events among patients with diabetes. But diabetic patients are still twice as likely to experience such events as people without diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.